nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—Ifosfamide—germ cell cancer	0.165	0.246	CbGbCtD
Efavirenz—CYP2C19—Ifosfamide—germ cell cancer	0.105	0.156	CbGbCtD
Efavirenz—CYP2C9—Ifosfamide—germ cell cancer	0.0873	0.13	CbGbCtD
Efavirenz—CYP2B6—Cisplatin—germ cell cancer	0.0804	0.12	CbGbCtD
Efavirenz—CYP3A4—Ifosfamide—germ cell cancer	0.0508	0.0757	CbGbCtD
Efavirenz—CYP1A2—Etoposide—germ cell cancer	0.0463	0.069	CbGbCtD
Efavirenz—CYP2C9—Cisplatin—germ cell cancer	0.0425	0.0633	CbGbCtD
Efavirenz—CYP2D6—Vinblastine—germ cell cancer	0.0423	0.0631	CbGbCtD
Efavirenz—CYP3A4—Vinblastine—germ cell cancer	0.0269	0.0401	CbGbCtD
Efavirenz—CYP3A4—Etoposide—germ cell cancer	0.0243	0.0362	CbGbCtD
Efavirenz—CYP2C9—cardial valve—germ cell cancer	0.00355	0.369	CbGeAlD
Efavirenz—CYP2C19—urine—germ cell cancer	0.000988	0.103	CbGeAlD
Efavirenz—CYP1A2—urine—germ cell cancer	0.000807	0.0838	CbGeAlD
Efavirenz—CYP2C9—urine—germ cell cancer	0.000766	0.0796	CbGeAlD
Efavirenz—CYP3A4—urine—germ cell cancer	0.000584	0.0607	CbGeAlD
Efavirenz—CYP2D6—urine—germ cell cancer	0.000575	0.0597	CbGeAlD
Efavirenz—Vertigo—Ifosfamide—germ cell cancer	0.000445	0.00139	CcSEcCtD
Efavirenz—Urinary tract disorder—Etoposide—germ cell cancer	0.000444	0.00139	CcSEcCtD
Efavirenz—Polyuria—Methotrexate—germ cell cancer	0.000443	0.00139	CcSEcCtD
Efavirenz—Immune system disorder—Cisplatin—germ cell cancer	0.000443	0.00139	CcSEcCtD
Efavirenz—Abdominal pain—Vinblastine—germ cell cancer	0.000443	0.00139	CcSEcCtD
Efavirenz—Mediastinal disorder—Cisplatin—germ cell cancer	0.000442	0.00138	CcSEcCtD
Efavirenz—Urethral disorder—Etoposide—germ cell cancer	0.000441	0.00138	CcSEcCtD
Efavirenz—Arrhythmia—Cisplatin—germ cell cancer	0.000438	0.00137	CcSEcCtD
Efavirenz—Palpitations—Ifosfamide—germ cell cancer	0.000438	0.00137	CcSEcCtD
Efavirenz—Alopecia—Cisplatin—germ cell cancer	0.000434	0.00136	CcSEcCtD
Efavirenz—Hepatic failure—Methotrexate—germ cell cancer	0.000433	0.00136	CcSEcCtD
Efavirenz—Cough—Ifosfamide—germ cell cancer	0.000432	0.00135	CcSEcCtD
Efavirenz—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000432	0.00135	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000431	0.00135	CcSEcCtD
Efavirenz—Convulsion—Ifosfamide—germ cell cancer	0.000429	0.00134	CcSEcCtD
Efavirenz—Hypertension—Ifosfamide—germ cell cancer	0.000428	0.00134	CcSEcCtD
Efavirenz—Erythema—Cisplatin—germ cell cancer	0.000427	0.00134	CcSEcCtD
Efavirenz—Malnutrition—Cisplatin—germ cell cancer	0.000427	0.00134	CcSEcCtD
Efavirenz—Erythema multiforme—Etoposide—germ cell cancer	0.000425	0.00133	CcSEcCtD
Efavirenz—Paraesthesia—Bleomycin—germ cell cancer	0.000425	0.00133	CcSEcCtD
Efavirenz—Dyspnoea—Bleomycin—germ cell cancer	0.000422	0.00132	CcSEcCtD
Efavirenz—Chest pain—Ifosfamide—germ cell cancer	0.000422	0.00132	CcSEcCtD
Efavirenz—Arthralgia—Ifosfamide—germ cell cancer	0.000422	0.00132	CcSEcCtD
Efavirenz—Myalgia—Ifosfamide—germ cell cancer	0.000422	0.00132	CcSEcCtD
Efavirenz—Renal failure acute—Methotrexate—germ cell cancer	0.000422	0.00132	CcSEcCtD
Efavirenz—Flatulence—Cisplatin—germ cell cancer	0.000421	0.00132	CcSEcCtD
Efavirenz—Anorexia—Dactinomycin—germ cell cancer	0.000421	0.00132	CcSEcCtD
Efavirenz—Eye disorder—Etoposide—germ cell cancer	0.00042	0.00131	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000419	0.00131	CcSEcCtD
Efavirenz—Flushing—Etoposide—germ cell cancer	0.000417	0.00131	CcSEcCtD
Efavirenz—Cardiac disorder—Etoposide—germ cell cancer	0.000417	0.00131	CcSEcCtD
Efavirenz—Discomfort—Ifosfamide—germ cell cancer	0.000417	0.0013	CcSEcCtD
Efavirenz—Hypersensitivity—Vinblastine—germ cell cancer	0.000413	0.00129	CcSEcCtD
Efavirenz—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000412	0.00129	CcSEcCtD
Efavirenz—Decreased appetite—Bleomycin—germ cell cancer	0.000411	0.00129	CcSEcCtD
Efavirenz—Angiopathy—Etoposide—germ cell cancer	0.000408	0.00128	CcSEcCtD
Efavirenz—Confusional state—Ifosfamide—germ cell cancer	0.000408	0.00128	CcSEcCtD
Efavirenz—Immune system disorder—Etoposide—germ cell cancer	0.000406	0.00127	CcSEcCtD
Efavirenz—Mediastinal disorder—Etoposide—germ cell cancer	0.000405	0.00127	CcSEcCtD
Efavirenz—Pain—Bleomycin—germ cell cancer	0.000405	0.00127	CcSEcCtD
Efavirenz—Vision blurred—Cisplatin—germ cell cancer	0.000402	0.00126	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000402	0.00126	CcSEcCtD
Efavirenz—Asthenia—Vinblastine—germ cell cancer	0.000402	0.00126	CcSEcCtD
Efavirenz—Tremor—Cisplatin—germ cell cancer	0.0004	0.00125	CcSEcCtD
Efavirenz—Alopecia—Etoposide—germ cell cancer	0.000397	0.00124	CcSEcCtD
Efavirenz—Nervous system disorder—Ifosfamide—germ cell cancer	0.000396	0.00124	CcSEcCtD
Efavirenz—Ill-defined disorder—Cisplatin—germ cell cancer	0.000396	0.00124	CcSEcCtD
Efavirenz—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000396	0.00124	CcSEcCtD
Efavirenz—Anaemia—Cisplatin—germ cell cancer	0.000395	0.00124	CcSEcCtD
Efavirenz—Skin disorder—Ifosfamide—germ cell cancer	0.000393	0.00123	CcSEcCtD
Efavirenz—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000391	0.00122	CcSEcCtD
Efavirenz—Feeling abnormal—Bleomycin—germ cell cancer	0.00039	0.00122	CcSEcCtD
Efavirenz—Anorexia—Ifosfamide—germ cell cancer	0.000385	0.00121	CcSEcCtD
Efavirenz—Malaise—Cisplatin—germ cell cancer	0.000385	0.00121	CcSEcCtD
Efavirenz—Decreased appetite—Dactinomycin—germ cell cancer	0.000384	0.0012	CcSEcCtD
Efavirenz—Diarrhoea—Vinblastine—germ cell cancer	0.000383	0.0012	CcSEcCtD
Efavirenz—Dysgeusia—Etoposide—germ cell cancer	0.000383	0.0012	CcSEcCtD
Efavirenz—Fatigue—Dactinomycin—germ cell cancer	0.00038	0.00119	CcSEcCtD
Efavirenz—Back pain—Etoposide—germ cell cancer	0.000378	0.00118	CcSEcCtD
Efavirenz—Pain—Dactinomycin—germ cell cancer	0.000377	0.00118	CcSEcCtD
Efavirenz—Urticaria—Bleomycin—germ cell cancer	0.000376	0.00118	CcSEcCtD
Efavirenz—Body temperature increased—Bleomycin—germ cell cancer	0.000374	0.00117	CcSEcCtD
Efavirenz—Dizziness—Vinblastine—germ cell cancer	0.00037	0.00116	CcSEcCtD
Efavirenz—Convulsion—Cisplatin—germ cell cancer	0.00037	0.00116	CcSEcCtD
Efavirenz—Mood swings—Methotrexate—germ cell cancer	0.000369	0.00115	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000368	0.00115	CcSEcCtD
Efavirenz—Ataxia—Methotrexate—germ cell cancer	0.000366	0.00115	CcSEcCtD
Efavirenz—Myalgia—Cisplatin—germ cell cancer	0.000364	0.00114	CcSEcCtD
Efavirenz—Feeling abnormal—Dactinomycin—germ cell cancer	0.000364	0.00114	CcSEcCtD
Efavirenz—Paraesthesia—Ifosfamide—germ cell cancer	0.000363	0.00114	CcSEcCtD
Efavirenz—Ill-defined disorder—Etoposide—germ cell cancer	0.000363	0.00114	CcSEcCtD
Efavirenz—Anxiety—Cisplatin—germ cell cancer	0.000362	0.00113	CcSEcCtD
Efavirenz—Anaemia—Etoposide—germ cell cancer	0.000362	0.00113	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000361	0.00113	CcSEcCtD
Efavirenz—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000361	0.00113	CcSEcCtD
Efavirenz—Dyspnoea—Ifosfamide—germ cell cancer	0.00036	0.00113	CcSEcCtD
Efavirenz—Somnolence—Ifosfamide—germ cell cancer	0.000359	0.00113	CcSEcCtD
Efavirenz—Discomfort—Cisplatin—germ cell cancer	0.000359	0.00112	CcSEcCtD
Efavirenz—Vomiting—Vinblastine—germ cell cancer	0.000356	0.00111	CcSEcCtD
Efavirenz—Malaise—Etoposide—germ cell cancer	0.000353	0.0011	CcSEcCtD
Efavirenz—Breast disorder—Methotrexate—germ cell cancer	0.000352	0.0011	CcSEcCtD
Efavirenz—Vertigo—Etoposide—germ cell cancer	0.000352	0.0011	CcSEcCtD
Efavirenz—Decreased appetite—Ifosfamide—germ cell cancer	0.000351	0.0011	CcSEcCtD
Efavirenz—Headache—Vinblastine—germ cell cancer	0.000351	0.0011	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00035	0.0011	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000349	0.00109	CcSEcCtD
Efavirenz—Body temperature increased—Dactinomycin—germ cell cancer	0.000349	0.00109	CcSEcCtD
Efavirenz—Abdominal pain—Dactinomycin—germ cell cancer	0.000349	0.00109	CcSEcCtD
Efavirenz—Fatigue—Ifosfamide—germ cell cancer	0.000349	0.00109	CcSEcCtD
Efavirenz—Hypersensitivity—Bleomycin—germ cell cancer	0.000349	0.00109	CcSEcCtD
Efavirenz—Constipation—Ifosfamide—germ cell cancer	0.000346	0.00108	CcSEcCtD
Efavirenz—Pain—Ifosfamide—germ cell cancer	0.000346	0.00108	CcSEcCtD
Efavirenz—Loss of consciousness—Etoposide—germ cell cancer	0.000344	0.00108	CcSEcCtD
Efavirenz—Nervous system disorder—Cisplatin—germ cell cancer	0.000342	0.00107	CcSEcCtD
Efavirenz—Cough—Etoposide—germ cell cancer	0.000341	0.00107	CcSEcCtD
Efavirenz—Thrombocytopenia—Cisplatin—germ cell cancer	0.000341	0.00107	CcSEcCtD
Efavirenz—Tachycardia—Cisplatin—germ cell cancer	0.00034	0.00106	CcSEcCtD
Efavirenz—Asthenia—Bleomycin—germ cell cancer	0.000339	0.00106	CcSEcCtD
Efavirenz—Convulsion—Etoposide—germ cell cancer	0.000339	0.00106	CcSEcCtD
Efavirenz—Skin disorder—Cisplatin—germ cell cancer	0.000339	0.00106	CcSEcCtD
Efavirenz—Hypertension—Etoposide—germ cell cancer	0.000338	0.00106	CcSEcCtD
Efavirenz—Hyperhidrosis—Cisplatin—germ cell cancer	0.000337	0.00105	CcSEcCtD
Efavirenz—Asthma—Methotrexate—germ cell cancer	0.000336	0.00105	CcSEcCtD
Efavirenz—Pruritus—Bleomycin—germ cell cancer	0.000335	0.00105	CcSEcCtD
Efavirenz—Feeling abnormal—Ifosfamide—germ cell cancer	0.000333	0.00104	CcSEcCtD
Efavirenz—Chest pain—Etoposide—germ cell cancer	0.000333	0.00104	CcSEcCtD
Efavirenz—Nausea—Vinblastine—germ cell cancer	0.000333	0.00104	CcSEcCtD
Efavirenz—Anorexia—Cisplatin—germ cell cancer	0.000332	0.00104	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000331	0.00104	CcSEcCtD
Efavirenz—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000331	0.00103	CcSEcCtD
Efavirenz—Pancreatitis—Methotrexate—germ cell cancer	0.00033	0.00103	CcSEcCtD
Efavirenz—Discomfort—Etoposide—germ cell cancer	0.000329	0.00103	CcSEcCtD
Efavirenz—Hypersensitivity—Dactinomycin—germ cell cancer	0.000325	0.00102	CcSEcCtD
Efavirenz—Confusional state—Etoposide—germ cell cancer	0.000322	0.00101	CcSEcCtD
Efavirenz—Urticaria—Ifosfamide—germ cell cancer	0.000321	0.00101	CcSEcCtD
Efavirenz—Abdominal pain—Ifosfamide—germ cell cancer	0.00032	0.001	CcSEcCtD
Efavirenz—Body temperature increased—Ifosfamide—germ cell cancer	0.00032	0.001	CcSEcCtD
Efavirenz—Pancytopenia—Methotrexate—germ cell cancer	0.000319	0.001	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000318	0.000994	CcSEcCtD
Efavirenz—Asthenia—Dactinomycin—germ cell cancer	0.000317	0.000991	CcSEcCtD
Efavirenz—Paraesthesia—Cisplatin—germ cell cancer	0.000313	0.00098	CcSEcCtD
Efavirenz—Thrombocytopenia—Etoposide—germ cell cancer	0.000313	0.000979	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000313	0.000979	CcSEcCtD
Efavirenz—Tachycardia—Etoposide—germ cell cancer	0.000312	0.000976	CcSEcCtD
Efavirenz—Dyspnoea—Cisplatin—germ cell cancer	0.000311	0.000973	CcSEcCtD
Efavirenz—Skin disorder—Etoposide—germ cell cancer	0.00031	0.000971	CcSEcCtD
Efavirenz—Hyperhidrosis—Etoposide—germ cell cancer	0.000309	0.000966	CcSEcCtD
Efavirenz—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000307	0.000961	CcSEcCtD
Efavirenz—Anorexia—Etoposide—germ cell cancer	0.000304	0.000953	CcSEcCtD
Efavirenz—Decreased appetite—Cisplatin—germ cell cancer	0.000303	0.000949	CcSEcCtD
Efavirenz—Diarrhoea—Dactinomycin—germ cell cancer	0.000302	0.000945	CcSEcCtD
Efavirenz—Pneumonia—Methotrexate—germ cell cancer	0.000302	0.000944	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000301	0.000942	CcSEcCtD
Efavirenz—Vomiting—Bleomycin—germ cell cancer	0.000301	0.000942	CcSEcCtD
Efavirenz—Infestation NOS—Methotrexate—germ cell cancer	0.0003	0.000939	CcSEcCtD
Efavirenz—Drowsiness—Methotrexate—germ cell cancer	0.0003	0.000939	CcSEcCtD
Efavirenz—Infestation—Methotrexate—germ cell cancer	0.0003	0.000939	CcSEcCtD
Efavirenz—Depression—Methotrexate—germ cell cancer	0.000299	0.000936	CcSEcCtD
Efavirenz—Rash—Bleomycin—germ cell cancer	0.000298	0.000934	CcSEcCtD
Efavirenz—Pain—Cisplatin—germ cell cancer	0.000298	0.000933	CcSEcCtD
Efavirenz—Dermatitis—Bleomycin—germ cell cancer	0.000298	0.000933	CcSEcCtD
Efavirenz—Hypersensitivity—Ifosfamide—germ cell cancer	0.000298	0.000933	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000297	0.000931	CcSEcCtD
Efavirenz—Renal failure—Methotrexate—germ cell cancer	0.000295	0.000923	CcSEcCtD
Efavirenz—Asthenia—Ifosfamide—germ cell cancer	0.00029	0.000908	CcSEcCtD
Efavirenz—Sweating—Methotrexate—germ cell cancer	0.000288	0.0009	CcSEcCtD
Efavirenz—Feeling abnormal—Cisplatin—germ cell cancer	0.000287	0.000899	CcSEcCtD
Efavirenz—Paraesthesia—Etoposide—germ cell cancer	0.000287	0.000898	CcSEcCtD
Efavirenz—Pruritus—Ifosfamide—germ cell cancer	0.000286	0.000895	CcSEcCtD
Efavirenz—Haematuria—Methotrexate—germ cell cancer	0.000286	0.000895	CcSEcCtD
Efavirenz—Dyspnoea—Etoposide—germ cell cancer	0.000285	0.000891	CcSEcCtD
Efavirenz—Somnolence—Etoposide—germ cell cancer	0.000284	0.000889	CcSEcCtD
Efavirenz—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000284	0.000888	CcSEcCtD
Efavirenz—Nausea—Bleomycin—germ cell cancer	0.000281	0.00088	CcSEcCtD
Efavirenz—Vomiting—Dactinomycin—germ cell cancer	0.000281	0.000878	CcSEcCtD
Efavirenz—Rash—Dactinomycin—germ cell cancer	0.000278	0.000871	CcSEcCtD
Efavirenz—Decreased appetite—Etoposide—germ cell cancer	0.000278	0.000869	CcSEcCtD
Efavirenz—Diarrhoea—Ifosfamide—germ cell cancer	0.000277	0.000866	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000276	0.000863	CcSEcCtD
Efavirenz—Body temperature increased—Cisplatin—germ cell cancer	0.000276	0.000863	CcSEcCtD
Efavirenz—Fatigue—Etoposide—germ cell cancer	0.000275	0.000862	CcSEcCtD
Efavirenz—Pain—Etoposide—germ cell cancer	0.000273	0.000855	CcSEcCtD
Efavirenz—Constipation—Etoposide—germ cell cancer	0.000273	0.000855	CcSEcCtD
Efavirenz—Hepatitis—Methotrexate—germ cell cancer	0.000269	0.000843	CcSEcCtD
Efavirenz—Dizziness—Ifosfamide—germ cell cancer	0.000267	0.000837	CcSEcCtD
Efavirenz—Urinary tract disorder—Methotrexate—germ cell cancer	0.000266	0.000832	CcSEcCtD
Efavirenz—Urethral disorder—Methotrexate—germ cell cancer	0.000264	0.000826	CcSEcCtD
Efavirenz—Feeling abnormal—Etoposide—germ cell cancer	0.000263	0.000824	CcSEcCtD
Efavirenz—Nausea—Dactinomycin—germ cell cancer	0.000262	0.00082	CcSEcCtD
Efavirenz—Gastrointestinal pain—Etoposide—germ cell cancer	0.000261	0.000817	CcSEcCtD
Efavirenz—Visual impairment—Methotrexate—germ cell cancer	0.000259	0.000812	CcSEcCtD
Efavirenz—Vomiting—Ifosfamide—germ cell cancer	0.000257	0.000805	CcSEcCtD
Efavirenz—Hypersensitivity—Cisplatin—germ cell cancer	0.000257	0.000804	CcSEcCtD
Efavirenz—Rash—Ifosfamide—germ cell cancer	0.000255	0.000798	CcSEcCtD
Efavirenz—Dermatitis—Ifosfamide—germ cell cancer	0.000255	0.000797	CcSEcCtD
Efavirenz—Erythema multiforme—Methotrexate—germ cell cancer	0.000255	0.000797	CcSEcCtD
Efavirenz—Urticaria—Etoposide—germ cell cancer	0.000254	0.000794	CcSEcCtD
Efavirenz—Abdominal pain—Etoposide—germ cell cancer	0.000252	0.00079	CcSEcCtD
Efavirenz—Body temperature increased—Etoposide—germ cell cancer	0.000252	0.00079	CcSEcCtD
Efavirenz—Eye disorder—Methotrexate—germ cell cancer	0.000252	0.000788	CcSEcCtD
Efavirenz—Tinnitus—Methotrexate—germ cell cancer	0.000251	0.000786	CcSEcCtD
Efavirenz—Asthenia—Cisplatin—germ cell cancer	0.00025	0.000783	CcSEcCtD
Efavirenz—Cardiac disorder—Methotrexate—germ cell cancer	0.00025	0.000782	CcSEcCtD
Efavirenz—Angiopathy—Methotrexate—germ cell cancer	0.000244	0.000765	CcSEcCtD
Efavirenz—Immune system disorder—Methotrexate—germ cell cancer	0.000243	0.000761	CcSEcCtD
Efavirenz—Mediastinal disorder—Methotrexate—germ cell cancer	0.000243	0.00076	CcSEcCtD
Efavirenz—Nausea—Ifosfamide—germ cell cancer	0.00024	0.000752	CcSEcCtD
Efavirenz—Diarrhoea—Cisplatin—germ cell cancer	0.000238	0.000747	CcSEcCtD
Efavirenz—Alopecia—Methotrexate—germ cell cancer	0.000238	0.000745	CcSEcCtD
Efavirenz—Hypersensitivity—Etoposide—germ cell cancer	0.000235	0.000736	CcSEcCtD
Efavirenz—Erythema—Methotrexate—germ cell cancer	0.000234	0.000734	CcSEcCtD
Efavirenz—Malnutrition—Methotrexate—germ cell cancer	0.000234	0.000734	CcSEcCtD
Efavirenz—Dysgeusia—Methotrexate—germ cell cancer	0.000229	0.000718	CcSEcCtD
Efavirenz—Asthenia—Etoposide—germ cell cancer	0.000229	0.000717	CcSEcCtD
Efavirenz—Back pain—Methotrexate—germ cell cancer	0.000227	0.00071	CcSEcCtD
Efavirenz—Pruritus—Etoposide—germ cell cancer	0.000226	0.000707	CcSEcCtD
Efavirenz—Vomiting—Cisplatin—germ cell cancer	0.000222	0.000694	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—germ cell cancer	0.000221	0.000691	CcSEcCtD
Efavirenz—Rash—Cisplatin—germ cell cancer	0.00022	0.000688	CcSEcCtD
Efavirenz—Dermatitis—Cisplatin—germ cell cancer	0.00022	0.000687	CcSEcCtD
Efavirenz—Diarrhoea—Etoposide—germ cell cancer	0.000218	0.000684	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—germ cell cancer	0.000217	0.000681	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—germ cell cancer	0.000217	0.000678	CcSEcCtD
Efavirenz—Malaise—Methotrexate—germ cell cancer	0.000211	0.000662	CcSEcCtD
Efavirenz—Dizziness—Etoposide—germ cell cancer	0.000211	0.000661	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—germ cell cancer	0.000211	0.000659	CcSEcCtD
Efavirenz—Nausea—Cisplatin—germ cell cancer	0.000207	0.000648	CcSEcCtD
Efavirenz—Cough—Methotrexate—germ cell cancer	0.000205	0.00064	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—germ cell cancer	0.000203	0.000636	CcSEcCtD
Efavirenz—Vomiting—Etoposide—germ cell cancer	0.000203	0.000636	CcSEcCtD
Efavirenz—Rash—Etoposide—germ cell cancer	0.000201	0.00063	CcSEcCtD
Efavirenz—Dermatitis—Etoposide—germ cell cancer	0.000201	0.00063	CcSEcCtD
Efavirenz—Headache—Etoposide—germ cell cancer	0.0002	0.000626	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—germ cell cancer	0.0002	0.000625	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—germ cell cancer	0.0002	0.000625	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—germ cell cancer	0.0002	0.000625	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000198	0.00062	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—germ cell cancer	0.000197	0.000617	CcSEcCtD
Efavirenz—CYP2B6—skin of body—germ cell cancer	0.000194	0.0202	CbGeAlD
Efavirenz—Confusional state—Methotrexate—germ cell cancer	0.000193	0.000604	CcSEcCtD
Efavirenz—Nausea—Etoposide—germ cell cancer	0.00019	0.000594	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—germ cell cancer	0.000188	0.000587	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—germ cell cancer	0.000187	0.000586	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—germ cell cancer	0.000186	0.000582	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—germ cell cancer	0.000185	0.000579	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—germ cell cancer	0.000182	0.000571	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000174	0.000546	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—germ cell cancer	0.000173	0.000542	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—germ cell cancer	0.000172	0.000538	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—germ cell cancer	0.000171	0.000534	CcSEcCtD
Efavirenz—CYP2D6—brainstem—germ cell cancer	0.00017	0.0177	CbGeAlD
Efavirenz—Somnolence—Methotrexate—germ cell cancer	0.00017	0.000532	CcSEcCtD
Efavirenz—CYP2B6—gonad—germ cell cancer	0.00017	0.0176	CbGeAlD
Efavirenz—Dyspepsia—Methotrexate—germ cell cancer	0.000168	0.000527	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—germ cell cancer	0.000166	0.000521	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000165	0.000517	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—germ cell cancer	0.000165	0.000516	CcSEcCtD
Efavirenz—CYP2C19—endocrine gland—germ cell cancer	0.000164	0.017	CbGeAlD
Efavirenz—Pain—Methotrexate—germ cell cancer	0.000164	0.000512	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—germ cell cancer	0.000158	0.000493	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000156	0.00049	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—germ cell cancer	0.000152	0.000476	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—germ cell cancer	0.000151	0.000473	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—germ cell cancer	0.000151	0.000473	CcSEcCtD
Efavirenz—CYP2D6—telencephalon—germ cell cancer	0.000151	0.0157	CbGeAlD
Efavirenz—CYP2B6—adrenal gland—germ cell cancer	0.000148	0.0154	CbGeAlD
Efavirenz—Hypersensitivity—Methotrexate—germ cell cancer	0.000141	0.000441	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—germ cell cancer	0.000137	0.00043	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—germ cell cancer	0.000135	0.000424	CcSEcCtD
Efavirenz—CYP1A2—endocrine gland—germ cell cancer	0.000134	0.0139	CbGeAlD
Efavirenz—Diarrhoea—Methotrexate—germ cell cancer	0.000131	0.00041	CcSEcCtD
Efavirenz—CYP2B6—endocrine gland—germ cell cancer	0.000128	0.0133	CbGeAlD
Efavirenz—CYP2C9—endocrine gland—germ cell cancer	0.000127	0.0132	CbGeAlD
Efavirenz—CYP2B6—head—germ cell cancer	0.000127	0.0132	CbGeAlD
Efavirenz—Dizziness—Methotrexate—germ cell cancer	0.000126	0.000396	CcSEcCtD
Efavirenz—CYP2B6—testis—germ cell cancer	0.000122	0.0127	CbGeAlD
Efavirenz—Vomiting—Methotrexate—germ cell cancer	0.000122	0.000381	CcSEcCtD
Efavirenz—Rash—Methotrexate—germ cell cancer	0.000121	0.000378	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—germ cell cancer	0.00012	0.000377	CcSEcCtD
Efavirenz—Headache—Methotrexate—germ cell cancer	0.00012	0.000375	CcSEcCtD
Efavirenz—Nausea—Methotrexate—germ cell cancer	0.000114	0.000356	CcSEcCtD
Efavirenz—CYP2D6—female gonad—germ cell cancer	0.000103	0.0106	CbGeAlD
Efavirenz—CYP3A4—endocrine gland—germ cell cancer	9.69e-05	0.0101	CbGeAlD
Efavirenz—CYP2D6—endocrine gland—germ cell cancer	9.54e-05	0.0099	CbGeAlD
Efavirenz—CYP2D6—head—germ cell cancer	9.41e-05	0.00977	CbGeAlD
Efavirenz—CYP2B6—brain—germ cell cancer	9.18e-05	0.00953	CbGeAlD
Efavirenz—CYP2D6—testis—germ cell cancer	9.09e-05	0.00944	CbGeAlD
Efavirenz—CYP2D6—cerebellum—germ cell cancer	8.4e-05	0.00872	CbGeAlD
Efavirenz—CYP2D6—brain—germ cell cancer	6.82e-05	0.00708	CbGeAlD
